Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
1
Active
204
Total enrollment
5
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Not applicable
2
Trials by status
Active, not recruiting
1
Completed
1
Unknown
1